In vitro methods to assess 11β-hydroxysteroid dehydrogenase type 2 activity
Methods in Enzymology · 2023
DOI: 10.1016/bs.mie.2023.04.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Enzymology, 2023. Verfasst von Manuel Kley und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Swiss Centre for Applie…. Hauptthemen laut MEDLINE: Mineralocorticoid Excess Syndrome, Apparent, Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Swiss Centre for Applied Human Toxicology, Department of Pharmaceutical Sciences, University…
- Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Zitieren
APA
Kley, M., Moser, S. O., Winter, D. V., & Odermatt, A. (2023). In vitro methods to assess 11β-hydroxysteroid dehydrogenase type 2 activity. Methods in Enzymology. https://doi.org/10.1016/bs.mie.2023.04.005
Vancouver
Kley M, Moser SO, Winter DV, Odermatt A. In vitro methods to assess 11β-hydroxysteroid dehydrogenase type 2 activity. Methods in Enzymology. 2023. doi:10.1016/bs.mie.2023.04.005
BibTeX
@article{Kley2023,
author = {Kley, Manuel and Moser, Seraina O and Winter, Denise V and Odermatt, Alex},
title = {In vitro methods to assess 11β-hydroxysteroid dehydrogenase type 2 activity},
journal = {Methods in Enzymology},
year = {2023},
doi = {10.1016/bs.mie.2023.04.005}
}
EUVIMED